Case report of renal manifestations in X-linked agammaglobulinemia.

X-linked Agammaglobulinemia inborn errors of immunity primary antibody deficiency renal disease tubulointerstitial lesions

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 25 01 2024
accepted: 14 05 2024
medline: 9 8 2024
pubmed: 9 8 2024
entrez: 9 8 2024
Statut: epublish

Résumé

X-linked agammaglobulinemia (XLA) is a humoral immunodeficiency disorder characterized by recurrent infections, severe hypogammaglobulinemia, and a deficiency of circulating B cells. While the hallmark clinical manifestations of XLA typically include the respiratory, dermatological, and gastrointestinal systems, renal involvement is infrequent. In this article, we report two cases of XLA with concurrent renal disease, supplemented with a review of documented cases. The two cases described involve twin brothers, both presenting with respiratory tract infections and renal manifestations. Subsequent genetic testing confirmed the diagnosis of XLA. The younger brother exhibited improvement following intravenous immunoglobulin (IVIG) therapy and anti-infection treatment. Due to financial constraints, the older brother received only anti-infection and symptomatic treatments. Seven months after discharge, the older brother developed nephritis. However, he showed improvement following IVIG treatment. Immune profiling and genetic testing should be considered in male children with recurrent infections to facilitate the effective diagnosis of XLA. Regular monitoring is also imperative to detect and treat immune-mediated renal diseases in patients with XLA.

Identifiants

pubmed: 39119334
doi: 10.3389/fimmu.2024.1376258
pmc: PMC11307147
doi:

Substances chimiques

Immunoglobulins, Intravenous 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1376258

Informations de copyright

Copyright © 2024 Wan, Cao, Zou, Bai, Shi and Jiang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Shuisen Wan (S)

Department of Pediatrics, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Meiling Cao (M)

Department of Neonatology, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Jiahui Zou (J)

Department of Pediatrics, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Yaojia Bai (Y)

Department of Pediatrics, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Mingyue Shi (M)

Department of Pediatrics, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Hongkun Jiang (H)

Department of Pediatrics, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH